Current Rheumatology Reports
Publication Venue For
Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis
Rituximab in ANCA-Associated Vasculitis
Infections With Biologics in Rheumatoid Arthritis and Related Conditions: a Scoping Review of Serious or Hospitalized Infections in Observational Studies
Racial/Ethnic Disparity in Rates and Outcomes of Total Joint Arthroplasty
Genetic Defects in Cytolysis in Macrophage Activation Syndrome
Vaccinations for rheumatoid arthritis
Racial and gender disparities among patients with gout
Osteopenia: Debates and dilemmas
What is the background incidence of malignancy in children with rheumatic disease?
Managing macrophages in rheumatoid arthritis by reform or removal
From fracture risk prediction to evaluating fracture patterns: Recent advances in the epidemiology of osteoporosis
Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies
Measurement of erythrocyte methotrexate polyglutamate levels: Ready for clinical use in rheumatoid arthritis?
Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: Cross-cultural issues
Bone changes and fracture risk in individuals infected with HIV
The societal burden of osteoporosis
Uric acid and hypertension: Cause or effect?
Quality of life and quality of care for patients with gout
Tumor necrosis factor inhibitors and infection complications
Update on pathogenic mechanisms of systemic necrotizing vasculitis
Improving quality of care in osteoporosis: Opportunities and challenges
The use of zoledronic acid for osteoporosis.
Therapeutic advances in calcium and vitamin D for osteoporosis.
Calcium and vitamin D: Skeletal and extraskeletal health
Denosumab in postmenopausal women with low bone mineral density.
Ibandronate injections in postmenopausal women with osteoporosis.
New directions in osteoporosis therapy: Intravenous ibandronate and denosumab
Not just calcium and vitamin D: Other nutritional considerations in osteoporosis
Uveitis: Advances in understanding of pathogenesis and treatment
Low-dose prednisolone in early rheumatoid arthritis
The use of low-dose glucocorticoids for the treatment of early rheumatoid arthritis: What can we learn about bone effects of glucocorticoids from randomized controlled trials?
Classification of the vasculitides: are they clinically useful?
Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?
Recent advances in the epidemiology of gout.
Update on autoantibodies in rheumatoid arthritis.
Ethnic disparities in patients with systemic lupus erythematosus.
Glucocorticoid use in rheumatoid arthritis.
Polyarteritis nodosa and microscopic polyangiitis: etiologic and diagnostic considerations.
Apoptosis and rheumatoid arthritis: past, present, and future directions.
Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia.
The genetics of rheumatoid arthritis: influences on susceptibility, severity, and treatment response.
International Standard Serial Number (issn)
Electronic International Standard Serial Number (eissn)